Title: SENATE BILL NO. 891 By: Murdock and Prieto of the
Official Title: SENATE BILL NO. 891 By: Murdock and Prieto of the
Number of Sections: 1
Source: versions - Policy Committee Recommendation
Media Type: application/pdf
Strikethrough Detection: 7 sections found

================================================================================

Section 1:
1 STATE OF OKLAHOMA
2 1st Session of the 60th Legislature (2025)
3 POLICY COMMITTEE
RECOMMENDATION
4 FOR ENGROSSED
5 Senate
6 and
7 Pae of the House
8
9 POLICY COMMITTEE RECOMMENDATION
10 An Act relating to kratom products; amending 63 O.S.
2021, Sections 1-1432.2 and 1-1432.4, as amended by
11 Section 1, Chapter 278, O.S.L. 2024 (63 O.S. Supp.
2024, Sections 1-1432.2 and 1-1432.4), which relates
12 to the Oklahoma Kratom Consumer Protection Act;
modifying definitions; removing certain packaging
13 requirements; removing a certain labeling
requirement; updating statutory reference; and
14 providing an effective date.
15
16
17 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
18 SECTION 1. AMENDATORY 63 O.S. 2021, Section 1-1432.2, as
19 amended by Section 1, Chapter 278, O.S.L. 2024 (63 O.S. Supp. 2024,
20 Section 1-1432.2), is amended to read as follows:
21 Section 1-1432.2. As used in this act the Oklahoma Kratom
22 Consumer Protection Act:
23 1. “Food” means a food, food product, food ingredient, dietary
24 ingredient, dietary supplement or beverage for human consumption;
Req. No. 13473 Page 1
1 2. “Kratom leaf” means the leaf of the kratom plant, Mitragyna
2 speciosa, in fresh or dehydrated or dried form that undergoes no
3 post-harvest processing other than drying or size reduction by
4 cutting, milling, or similar procedure, and may be cleaned or
5 sterilized using standard treatments applied to food ingredients,
6 such as heat, steam, pressurization, or irradiation or other
7 standard treatments applied to food ingredients. The total alkaloid
8 content of kratom leaf material used in the kratom product shall not
9 exceed three and one-half percent (3.5%) measured on a dried weight-
10 to-weight basis;
11 3. “Kratom leaf extract” means the material obtained by
12 extracting kratom using a solvent consisting of:
13 a. water, ethanol, or food-grade carbon dioxide (CO ), or
2
14 b. any other solvent allowed by federal or state
15 regulation for use in manufacturing a food ingredient.
16 The extracted material shall contain mitragynine as the most
17 abundant alkaloid, measured on a weight-to-weight basis, and at a
18 level that is equal to or exceeds twice that of any other alkaloid
19 present. The ratio of mitragynine to other alkaloids in the extract
20 shall be equal to or greater than the ratio found in the starting
21 material;
22 4. “Kratom product” means a food or dietary supplement that
23 consists of or contains kratom leaf or kratom leaf extract that does
24 not contain any synthesized kratom alkaloids, other synthesized
Req. No. 13473 Page 2
1 krat om constituents, or synthesized metabolites of any kratom
2 constituent in which the level of 7-hydroxymitragynine, on a percent
3 weight basis, is not greater than one percent (1%) of the amount of
4 total kratom alkaloids, as confirmed with a high-performance liquid
5 chromatography testing method. For purposes of this paragraph,
6 “synthesized” refers to substances produced using directed synthetic
7 or biosynthetic chemistry, as opposed to traditional food
8 preparation techniques such as heating or extracting;
9 5. “Total kratom alkaloids” means the sum of mitragynine,
10 speciociliatine, speciogynine, paynantheine, and 7-
11 hydroxymitragynine; and
12 6. “Vendor” means a person or entity that sells, prepares or
13 maintains kratom products or that advertises, represents or holds
14 himself, herself, or itself out as selling, preparing or maintaining
15 kratom products and includes a manufacturer, wholesaler, store,
16 restaurant, hotel, catering facility, camp, bakery, delicatessen,
17 supermarket, grocery store, convenience store, nursing home or food
18 or drink company.
19 SECTION 2. AMENDATORY 63 O.S. 2021, Section 1-1432.4, as
20 amended by Section 2, Chapter 278, O.S.L. 2024 (63 O.S. Supp. 2024,
21 Section 1-1432.4), is amended to read as follows:
22 Section 1-1432.4. A. A vendor shall not prepare, distribute,
23 sell or expose for sale any of the following:
24
Req. No. 13473 Page 3
1 1. A kratom product that does not meet the definition for a
2 kratom product pursuant to Section 1-1432.2 of this title;
3 2. A kratom product that is contaminated with a dangerous
4 nonkratom substance. A kratom product is contaminated with a
5 dangerous nonkratom substance if the kratom product contains a
6 substance that is not safe for human consumption;
7 3. A kratom product containing a level of 7-hydroxymitragynine
8 in the alkaloid fraction that is greater than one percent (1%) of
9 the alkaloid composition of the product;
10 4. A kratom product containing any synthesized alkaloid
11 including synthesized mitragynine, synthesized 7-hydroxymitragynine
12 or any other synthesized compounds of the kratom plant;
13 5. A kratom product containing any controlled substance listed
14 in the Uniform Controlled Dangerous Substances Act, unless the
15 product is compounded by a licensed pharmacist with the controlled
16 substance dispensed in accordance with a valid prescription; or
17 6. A kratom product containing a level of any residual solvent
18 that was used in the manufacturing of the extract that exceeds the
19 residual level specified for pharmaceutical products in the document
20 "Q3C - Tables and List, Guidance for Industry, [June 2017] ICH
21 Revision 3" issued by the United States Department of Health and
22 Human Services, Food and Drug Administration.
23 B. Kratom products shall be accompanied by a label bearing the
24 following information prior to its sale in this state:
Req. No. 13473 Page 4
1 1. A list of the ingredients, which shall include the common or
2 usual name of each ingredient used in the manufacture of the
3 product, listed in descending order of predominance;
4 2. That the sale or transfer of kratom to a person under
5 eighteen (18) years of age is prohibited;
6 3. The amount of total kratom alkaloids, mitragynine, and 7-
7 hydroxymitragynine contained in the product;
8 4. The amount of total kratom alkaloids, mitragynine, and 7-
9 hydroxymitragynine contained in packaging for the product;
10 5. The name and the principal street address of the vendor or
11 the person responsible for distributing the product;
12 6. Any federal food allergen labeling requirements, if
13 applicable, and clear and adequate directions for the consumption
14 and safe and effective use of such product, including the
15 recommended serving size, the number of servings in the container,
16 and the number of servings that can be safely consumed in a day.
17 Provided, liquid kratom products shall be packaged in a retail
18 container that has clear serving size markings and be subject to the
19 following requirements:
20 a. products of less than eight (8) fluid ounces which
21 contain more than three servings shall be accompanied
22 by a calibrated measuring device, and
23
24
Req. No. 13473 Page 5
1 b. if such a product contains more than the eight (8)
2 fluid ounces, the requirements specified in
3 subparagraph a of this paragraph do not apply.
4 Provided further, packaging for powdered kratom products not in
5 capsule form shall have a calibrated measuring device included in
6 the container;
7 7. Any precautionary statements as to the safety and
8 effectiveness of the product, including a warning that a consumer
9 should consult a health care professional on questions about the use
10 of kratom, that the product may be habit-forming, and a statement
11 that the kratom product is not intended to "diagnose, treat, cure,
12 or prevent any disease"; and
13 8. A statement that a kratom product label is prohibited from
14 making any therapeutic claims unless approved by the United States
15 Food and Drug Administration says “These statements have not been
16 evaluated by the United States Food and Drug Administration. This
17 product is not intended to diagnose, treat, cure, or prevent any
18 disease”.
19 C. A vendor may not distribute, sell or expose for sale a
20 kratom product to an individual under eighteen (18) years of age.
21 D. Upon request by the State Department of Health, the vendor
22 shall provide test results from a United States-based testing
23 facility to confirm the items listed on the product label.
24
Req. No. 13473 Page 6
1 SECTION 3. This act shall become effective November 1, 2025.
2
3 60-1-13473 JL 04/09/25
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
Req. No. 13473 Page 7
[DELETED:  PS B M  a P]
[DELETED:  P wO) a]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P p]
[DELETED:  P i]
[DELETED:  P J 0]


================================================================================

Raw Text:
1 STATE OF OKLAHOMA
2 1st Session of the 60th Legislature (2025)
3 POLICY COMMITTEE
RECOMMENDATION
4 FOR ENGROSSED
SENATE BILL NO. 891 By: Murdock and Prieto of the
5 Senate
6 and
7 Pae of the House
8
9 POLICY COMMITTEE RECOMMENDATION
10 An Act relating to kratom products; amending 63 O.S.
2021, Sections 1-1432.2 and 1-1432.4, as amended by
11 Section 1, Chapter 278, O.S.L. 2024 (63 O.S. Supp.
2024, Sections 1-1432.2 and 1-1432.4), which relates
12 to the Oklahoma Kratom Consumer Protection Act;
modifying definitions; removing certain packaging
13 requirements; removing a certain labeling
requirement; updating statutory reference; and
14 providing an effective date.
15
16
17 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
18 SECTION 1. AMENDATORY 63 O.S. 2021, Section 1-1432.2, as
19 amended by Section 1, Chapter 278, O.S.L. 2024 (63 O.S. Supp. 2024,
20 Section 1-1432.2), is amended to read as follows:
21 Section 1-1432.2. As used in this act the Oklahoma Kratom
22 Consumer Protection Act:
23 1. “Food” means a food, food product, food ingredient, dietary
24 ingredient, dietary supplement or beverage for human consumption;
Req. No. 13473 Page 1

1 2. “Kratom leaf” means the leaf of the kratom plant, Mitragyna
2 speciosa, in fresh or dehydrated or dried form that undergoes no
3 post-harvest processing other than drying or size reduction by
4 cutting, milling, or similar procedure, and may be cleaned or
5 sterilized using standard treatments applied to food ingredients,
6 such as heat, steam, pressurization, or irradiation or other
7 standard treatments applied to food ingredients. The total alkaloid
8 content of kratom leaf material used in the kratom product shall not
9 exceed three and one-half percent (3.5%) measured on a dried weight-
10 to-weight basis;
11 3. “Kratom leaf extract” means the material obtained by
12 extracting kratom using a solvent consisting of:
13 a. water, ethanol, or food-grade carbon dioxide (CO ), or
2
14 b. any other solvent allowed by federal or state
15 regulation for use in manufacturing a food ingredient.
16 The extracted material shall contain mitragynine as the most
17 abundant alkaloid, measured on a weight-to-weight basis, and at a
18 level that is equal to or exceeds twice that of any other alkaloid
19 present. The ratio of mitragynine to other alkaloids in the extract
20 shall be equal to or greater than the ratio found in the starting
21 material;
22 4. “Kratom product” means a food or dietary supplement that
23 consists of or contains kratom leaf or kratom leaf extract that does
24 not contain any synthesized kratom alkaloids, other synthesized
Req. No. 13473 Page 2

1 krat om constituents, or synthesized metabolites of any kratom
2 constituent in which the level of 7-hydroxymitragynine, on a percent
3 weight basis, is not greater than one percent (1%) of the amount of
4 total kratom alkaloids, as confirmed with a high-performance liquid
5 chromatography testing method. For purposes of this paragraph,
6 “synthesized” refers to substances produced using directed synthetic
7 or biosynthetic chemistry, as opposed to traditional food
8 preparation techniques such as heating or extracting;
9 5. “Total kratom alkaloids” means the sum of mitragynine,
10 speciociliatine, speciogynine, paynantheine, and 7-
11 hydroxymitragynine; and
12 6. “Vendor” means a person or entity that sells, prepares or
13 maintains kratom products or that advertises, represents or holds
14 himself, herself, or itself out as selling, preparing or maintaining
15 kratom products and includes a manufacturer, wholesaler, store,
16 restaurant, hotel, catering facility, camp, bakery, delicatessen,
17 supermarket, grocery store, convenience store, nursing home or food
18 or drink company.
19 SECTION 2. AMENDATORY 63 O.S. 2021, Section 1-1432.4, as
20 amended by Section 2, Chapter 278, O.S.L. 2024 (63 O.S. Supp. 2024,
21 Section 1-1432.4), is amended to read as follows:
22 Section 1-1432.4. A. A vendor shall not prepare, distribute,
23 sell or expose for sale any of the following:
24
Req. No. 13473 Page 3

1 1. A kratom product that does not meet the definition for a
2 kratom product pursuant to Section 1-1432.2 of this title;
3 2. A kratom product that is contaminated with a dangerous
4 nonkratom substance. A kratom product is contaminated with a
5 dangerous nonkratom substance if the kratom product contains a
6 substance that is not safe for human consumption;
7 3. A kratom product containing a level of 7-hydroxymitragynine
8 in the alkaloid fraction that is greater than one percent (1%) of
9 the alkaloid composition of the product;
10 4. A kratom product containing any synthesized alkaloid
11 including synthesized mitragynine, synthesized 7-hydroxymitragynine
12 or any other synthesized compounds of the kratom plant;
13 5. A kratom product containing any controlled substance listed
14 in the Uniform Controlled Dangerous Substances Act, unless the
15 product is compounded by a licensed pharmacist with the controlled
16 substance dispensed in accordance with a valid prescription; or
17 6. A kratom product containing a level of any residual solvent
18 that was used in the manufacturing of the extract that exceeds the
19 residual level specified for pharmaceutical products in the document
20 "Q3C - Tables and List, Guidance for Industry, [June 2017] ICH
21 Revision 3" issued by the United States Department of Health and
22 Human Services, Food and Drug Administration.
23 B. Kratom products shall be accompanied by a label bearing the
24 following information prior to its sale in this state:
Req. No. 13473 Page 4

1 1. A list of the ingredients, which shall include the common or
2 usual name of each ingredient used in the manufacture of the
3 product, listed in descending order of predominance;
4 2. That the sale or transfer of kratom to a person under
5 eighteen (18) years of age is prohibited;
6 3. The amount of total kratom alkaloids, mitragynine, and 7-
7 hydroxymitragynine contained in the product;
8 4. The amount of total kratom alkaloids, mitragynine, and 7-
9 hydroxymitragynine contained in packaging for the product;
10 5. The name and the principal street address of the vendor or
11 the person responsible for distributing the product;
12 6. Any federal food allergen labeling requirements, if
13 applicable, and clear and adequate directions for the consumption
14 and safe and effective use of such product, including the
15 recommended serving size, the number of servings in the container,
16 and the number of servings that can be safely consumed in a day.
17 Provided, liquid kratom products shall be packaged in a retail
18 container that has clear serving size markings and be subject to the
19 following requirements:
20 a. products of less than eight (8) fluid ounces which
21 contain more than three servings shall be accompanied
22 by a calibrated measuring device, and
23
24
Req. No. 13473 Page 5

1 b. if such a product contains more than the eight (8)
2 fluid ounces, the requirements specified in
3 subparagraph a of this paragraph do not apply.
4 Provided further, packaging for powdered kratom products not in
5 capsule form shall have a calibrated measuring device included in
6 the container;
7 7. Any precautionary statements as to the safety and
8 effectiveness of the product, including a warning that a consumer
9 should consult a health care professional on questions about the use
10 of kratom, that the product may be habit-forming, and a statement
11 that the kratom product is not intended to "diagnose, treat, cure,
12 or prevent any disease"; and
13 8. A statement that a kratom product label is prohibited from
14 making any therapeutic claims unless approved by the United States
15 Food and Drug Administration says “These statements have not been
16 evaluated by the United States Food and Drug Administration. This
17 product is not intended to diagnose, treat, cure, or prevent any
18 disease”.
19 C. A vendor may not distribute, sell or expose for sale a
20 kratom product to an individual under eighteen (18) years of age.
21 D. Upon request by the State Department of Health, the vendor
22 shall provide test results from a United States-based testing
23 facility to confirm the items listed on the product label.
24
Req. No. 13473 Page 6

1 SECTION 3. This act shall become effective November 1, 2025.
2
3 60-1-13473 JL 04/09/25
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
Req. No. 13473 Page 7

[DELETED:  PS B M  a P]
[DELETED:  P wO) a]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P p]
[DELETED:  P i]
[DELETED:  P J 0]